Early Lung Cancer Detection Blood Test
Benefits
Early detection of lung cancer through a simple blood test using machine learning to identify biomarkers. When lung cancer is diagnosed early, patient survival rate increases tenfold. The test aims to detect lung cancer earlier than CT scans, potentially transforming cancer care pathways, reducing anxiety, improving quality of life for high-risk patients, and resulting in substantial financial benefits for the NHS.
Details
- Tool name
- Early Lung Cancer Detection Blood Test
- Organisation
- Oxford University Hospitals NHS Foundation Trust
- Status
- pilot
- AI method (as recorded)
- Machine Learning
- AI method (normalised tags)
- Machine Learning
- Usecase
- Health AI
- Origin
- ouh.nhs.uk
- Owning team
- Oxford University Hospitals NHS Foundation Trust, Oxford Radcliffe Biobank, and Oxford Cancer Analytics (OXcan)
- Date added
- 16 December 2022
- Scrape date
- Source note
- The study will recruit 200 participants to identify cancer biomarkers in blood samples. It runs until December 2025 and uses machine learning software to analyze protein data in liquid biopsies to identify biomarker signatures indicating early-stage lung cancer. The research addresses the critical need for early detection, as lung cancer is the most common cause of cancer death in the UK (21% of deaths) with over 75% of patients diagnosed at advanced stages. [Source]
- Source URL
- https://www.ouh.nhs.uk/news/articles/1859/